Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Malcolm Debaun

Orthopaedic Trauma Seattle, WA Medical Doctor

NPI 1134509003 CMS profile 2788903

325 9Th Ave, Seattle, WA 98104

Open in the dashboard

General payments

$227,892

303 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$300

1 holding reported · through program year 2025

Research they led as principal investigator

$142,755 paid to institutions, not to them · program year 2025

Through program year 2025, Malcolm Debaun of Seattle, WA is reported in the CMS Open Payments database as having received $227,892 across 303 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $142,755 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $300 across 1 holding.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 92nd percentile of Orthopaedic Trauma profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $71,013 93
2024 General $93,651 105
2023 General $44,758 48
2022 General $16,693 48
2021 General $1,625 7
2020 General $152 2
2025 Ownership $300 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Malcolm Debaun
  • Orthopaedic Trauma median
  • Middle half of Orthopaedic Trauma
  • National median

In program year 2025, general payments to Malcolm Debaun were reported at $71,013. Among 734 Orthopaedic Trauma profiles paid that year, the median was $1,227 and the middle half received between $259 and $7,433.

Show as a table
Year Malcolm Debaun Orthopaedic Trauma median Middle half National median
2019 $0 $1,475 $264–$6,401 $163
2020 $152 $596 $120–$4,020 $114
2021 $1,625 $919 $171–$4,697 $132
2022 $16,693 $1,547 $272–$7,240 $149
2023 $44,758 $1,330 $247–$5,875 $160
2024 $93,651 $1,288 $277–$6,797 $164
2025 $71,013 $1,227 $259–$7,433 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Medical Device Business Services, Inc. $126,644 116 payments
  2. SI-BONE, Inc. $53,905 48 payments
  3. OsteoCentric Technologies, Inc. $14,546 22 payments
  4. Synthes GmbH $13,265 21 payments
  5. Synthes USA Products LLC $7,005 15 payments
  6. Next Science LLC $2,886 10 payments
  7. DePuy Synthes Sales Inc. $2,660 35 payments
  8. New Standard Device, LLC dba Metalogix $2,050 1 payment
  9. Summit Surgical Corp. $1,218 2 payments
  10. Zimmer Biomet Holdings, Inc. $810 11 payments
  11. Other $2,904 22 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Consulting Fee $178,091 60 payments
  2. Travel and Lodging $31,727 83 payments
  3. Food and Beverage $11,624 155 payments
  4. Compensation for serving as faculty or as a speaker for a medical education program $5,250 4 payments
  5. Education $1,200 1 payment
Products named General payments · program years 2020–2025
  1. VA-LCP $115,662 54 payments
  2. IFUSE IMPLANT SYSTEM sacroiliac joint dysfunction $49,772 27 payments
  3. OsteoCentric 4.0 x 130mm LOCKING BONE SCREW FASTENER ST $14,546 22 payments
  4. NA Trauma $5,892 29 payments
  5. LCP $4,307 8 payments
  6. SurgX $2,744 6 payments
  7. Xperience $2,744 6 payments
  8. IFUSE IMPLANT $1,750 2 payments
  9. IFUSE IMPLANT SYSTEM sacroiliac joint dysfunction $1,657 3 payments
  10. NA Trauma $1,482 16 payments
  11. Other $4,856 65 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

11

Median for Orthopedic Surgery: 203

Drug cost

$125

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 11 $125

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 69 billing codes

Paid by Medicare

$75,648

Medicare's payments for the services billed

Medicare patients

132

Average age 73

Services billed

231

86 women, 46 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 67%
Osteoporosis 46%
Depression 37%
Diabetes 33%
Chronic kidney disease 33%
Ischemic heart disease 25%
Atrial fibrillation 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

303 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Trauma in Washington

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record